POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $815,081 | +39.5% | 342,471 | +3.1% | 0.00% | – |
| Q2 2023 | $584,366 | -24.8% | 332,026 | +31.7% | 0.00% | – |
| Q1 2023 | $776,616 | +683.8% | 252,148 | +1248.7% | 0.00% | – |
| Q4 2022 | $99,089 | +7.7% | 18,696 | -28.9% | 0.00% | – |
| Q3 2022 | $92,000 | +55.9% | 26,283 | +15.3% | 0.00% | – |
| Q2 2022 | $59,000 | -58.7% | 22,799 | -28.2% | 0.00% | – |
| Q1 2022 | $143,000 | -37.0% | 31,749 | -4.7% | 0.00% | – |
| Q4 2021 | $227,000 | +6.6% | 33,323 | +14.0% | 0.00% | – |
| Q3 2021 | $213,000 | -17.8% | 29,235 | +13.1% | 0.00% | – |
| Q2 2021 | $259,000 | +77.4% | 25,851 | +68.8% | 0.00% | – |
| Q1 2021 | $146,000 | +102.8% | 15,317 | +132.0% | 0.00% | – |
| Q4 2020 | $72,000 | -22.6% | 6,603 | -37.5% | 0.00% | – |
| Q3 2020 | $93,000 | – | 10,570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |